Establishing a Sustainable Gene Therapy Pipeline for Inherited Retinal Diseases

Time: 2:55 pm
day: Day One Track B - Afternoon

Details:

  • Challenges and solutions for creating a sustainable gene therapy pipeline for rare
    inherited retinal diseases
  • Opus Genetics’ gene therapy portfolio for LCA and other classes of IRDs
  • A Phase 1 trial for LCA5-IRD

Speakers: